Andrea D. Branch

5.4k total citations
127 papers, 3.5k citations indexed

About

Andrea D. Branch is a scholar working on Hepatology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Andrea D. Branch has authored 127 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 82 papers in Hepatology, 72 papers in Epidemiology and 15 papers in Infectious Diseases. Recurrent topics in Andrea D. Branch's work include Hepatitis C virus research (65 papers), Liver Disease Diagnosis and Treatment (50 papers) and Hepatitis B Virus Studies (33 papers). Andrea D. Branch is often cited by papers focused on Hepatitis C virus research (65 papers), Liver Disease Diagnosis and Treatment (50 papers) and Hepatitis B Virus Studies (33 papers). Andrea D. Branch collaborates with scholars based in United States, United Kingdom and Australia. Andrea D. Branch's co-authors include Decherd Stump, José L. Walewski, Charles M. Rice, Sarah L. Fishman, Hugh D. Robertson, Julio Gutiérrez, Thomas D. Schiano, Francis J. Eng, Douglas T. Dieterich and Shihyun You and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Andrea D. Branch

122 papers receiving 3.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andrea D. Branch United States 35 2.0k 1.9k 622 327 259 127 3.5k
Philip McCloud Australia 22 1.6k 0.8× 1.8k 1.0× 331 0.5× 217 0.7× 120 0.5× 52 3.7k
Yasuyuki Arakawa Japan 29 2.9k 1.4× 2.5k 1.4× 444 0.7× 417 1.3× 166 0.6× 121 4.2k
Alessandra Vitelli Italy 28 2.1k 1.0× 2.4k 1.3× 597 1.0× 357 1.1× 103 0.4× 55 4.4k
Mohammad Kazemi Arababadi Iran 30 617 0.3× 1.2k 0.7× 528 0.8× 207 0.6× 257 1.0× 189 3.1k
A. De Santis Italy 30 1.6k 0.8× 1.6k 0.8× 368 0.6× 158 0.5× 162 0.6× 112 3.3k
Tatsuki Ichikawa Japan 29 1.3k 0.6× 1.5k 0.8× 798 1.3× 102 0.3× 193 0.7× 155 3.2k
Douglas R. LaBrecque United States 33 1.7k 0.9× 1.7k 0.9× 420 0.7× 218 0.7× 394 1.5× 84 3.3k
Katharine M. Irvine Australia 36 873 0.4× 1.3k 0.7× 1.7k 2.7× 147 0.4× 223 0.9× 116 4.4k
Giuseppe Di Pasquale Italy 30 866 0.4× 1.1k 0.6× 394 0.6× 141 0.4× 100 0.4× 154 2.9k
Robert L. Peters United States 38 2.0k 1.0× 2.2k 1.2× 764 1.2× 327 1.0× 549 2.1× 122 4.6k

Countries citing papers authored by Andrea D. Branch

Since Specialization
Citations

This map shows the geographic impact of Andrea D. Branch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrea D. Branch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrea D. Branch more than expected).

Fields of papers citing papers by Andrea D. Branch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrea D. Branch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrea D. Branch. The network helps show where Andrea D. Branch may publish in the future.

Co-authorship network of co-authors of Andrea D. Branch

This figure shows the co-authorship network connecting the top 25 collaborators of Andrea D. Branch. A scholar is included among the top collaborators of Andrea D. Branch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrea D. Branch. Andrea D. Branch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Branch, Andrea D., et al.. (2025). Translating Hepatitis D Virus Screening Cost-Effectiveness into Practice: The Case for Reflex Testing in the United States. Clinical Infectious Diseases. 81(5). e474–e475.
2.
Naghavi, Morteza, Abbas Azimi, Anthony P. Reeves, et al.. (2025). Artificial Intelligence-derived Myosteatosis On Cardiac CT And Incident COPD Risk: An AI-CVD Study. Journal of cardiovascular computed tomography. 19(4). S64–S65.
3.
Naghavi, Morteza, et al.. (2025). AI Measurement Of Myosteatosis In Cardiac CT Predicts Atrial Fibrillation And Heart Failure: An AI-CVD Study. Journal of cardiovascular computed tomography. 19(4). S70–S70.
4.
Bansal, Meena B., et al.. (2024). Heavy metals are liver fibrosis risk factors in people without traditional liver disease etiologies. Journal of Environmental Sciences. 155. 329–342. 1 indexed citations
5.
Eng, Francis J., Stephen C. Ward, Thomas D. Schiano, et al.. (2024). Single‐cell RNA sequencing data identify a conserved population of metallothionein‐expressing macrophages that may be ubiquitous in vital human organs. SHILAP Revista de lepidopterología. 4(5). 1 indexed citations
6.
Sarpel, Umut, et al.. (2024). The adverse characteristics of hepatocellular carcinoma in the non‐cirrhotic liver disproportionately disadvantage Black patients. Cancer Medicine. 13(3). e6654–e6654. 2 indexed citations
7.
Bansal, Meena B., et al.. (2024). Fibrosis and steatotic liver disease in US adolescents according to the new nomenclature. Journal of Pediatric Gastroenterology and Nutrition. 79(2). 229–237. 10 indexed citations
8.
Doyle, Erin, Ashley Stueck, Nicolas Goossens, et al.. (2023). Hepatocellular carcinoma in patients cured of chronic hepatitis C: Minimal steatosis. Cancer Medicine. 12(9). 10175–10186. 6 indexed citations
9.
Yip, Rowena, Sara Lewis, Amreen Dinani, et al.. (2023). Environmental exposures are important risk factors for advanced liver fibrosis in African American adults. JHEP Reports. 5(4). 100696–100696. 23 indexed citations
10.
Buti, Marı́a, Andrea D. Branch, Manuel Mendizábal, et al.. (2023). IDDF2023-ABS-0299 Effectiveness of relink initiatives to re-engage diagnosed-but-untreated HCV-positive patients with direct-acting antiviral treatment. A172.1–A172. 1 indexed citations
11.
Park, Jiwoon, Yuanyuan Zhao, Fan Zhang, et al.. (2022). IL-6/STAT3 axis dictates the PNPLA3-mediated susceptibility to non-alcoholic fatty liver disease. Journal of Hepatology. 78(1). 45–56. 84 indexed citations
12.
Hernandez‐Meza, Gabriela, Naïk Vietti Violi, Daniela Said, et al.. (2021). MRI is the most commonly used imaging modality for HCC screening at a tertiary care transplant center. Abdominal Radiology. 46(11). 5142–5151. 5 indexed citations
13.
Dharmapuri, Sirish, Umut Özbek, Jung‐Yi Lin, et al.. (2020). Predictive value of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in advanced hepatocellular carcinoma patients treated with anti–PD‐1 therapy. Cancer Medicine. 9(14). 4962–4970. 82 indexed citations
14.
Branch, Andrea D., Minhee Kang, Kimberly Hollabaugh, et al.. (2013). In HIV/hepatitis C virus co-infected patients, higher 25-hydroxyvitamin D concentrations were not related to hepatitis C virus treatment responses but were associated with ritonavir use. American Journal of Clinical Nutrition. 98(2). 423–429. 6 indexed citations
15.
Fishman, Sarah L., Julio Gutiérrez, Christina Wyatt, et al.. (2010). Short Communication: Inadequate Vitamin D Exacerbates Parathyroid Hormone Elevations in Tenofovir Users. AIDS Research and Human Retroviruses. 26(8). 855–859. 55 indexed citations
16.
Fishman, Sarah L., Stephanie H. Factor, Cinzia Balestrieri, et al.. (2009). Mutations in the Hepatitis C Virus core Gene Are Associated with Advanced Liver Disease and Hepatocellular Carcinoma. Clinical Cancer Research. 15(9). 3205–3213. 66 indexed citations
17.
McMullan, Laura K., Arash Grakoui, Matthew J. Evans, et al.. (2007). Evidence for a functional RNA element in the hepatitis C virus core gene. Proceedings of the National Academy of Sciences. 104(8). 2879–2884. 95 indexed citations
18.
Wen, Feng, Maher Y. Abdalla, Costica Aloman, et al.. (2003). Increased prooxidant production and enhanced susceptibility to glutathione depletion in HepG2 cells co‐expressing HCV core protein and CYP2E1. Journal of Medical Virology. 72(2). 230–240. 37 indexed citations
19.
Branch, Andrea D., Leonard B. Seeff, & Paul D. Berk. (2000). Hepatitis C: state of the art at the millennium. Thieme eBooks. 24 indexed citations
20.
Branch, Andrea D.. (1996). Replication of hepatitis C virus: Catching it in the act. Hepatology. 23(2). 372–375. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Philip McCloud Breakdown of academic impact, for papers by Yasuyuki Arakawa Breakdown of academic impact, for papers by Alessandra Vitelli Breakdown of academic impact, for papers by Mohammad Kazemi Arababadi Breakdown of academic impact, for papers by A. De Santis Breakdown of academic impact, for papers by Tatsuki Ichikawa Breakdown of academic impact, for papers by Douglas R. LaBrecque Breakdown of academic impact, for papers by Katharine M. Irvine Breakdown of academic impact, for papers by Giuseppe Di Pasquale Breakdown of academic impact, for papers by Robert L. Peters
Rankless by CCL
2026